Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Hyperekplexia: A treatable neurogenetic disease
Lan Zhou
, Kipp L. Chillag
, Michael A. Nigro
Research output
:
Contribution to journal
›
Review article
›
peer-review
113
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hyperekplexia: A treatable neurogenetic disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hyperekplexia
100%
Neurogenetic Disorders
100%
Glycine Receptor
75%
Chloride Channel
75%
GLRA1
75%
Channel Function
50%
Pathophysiology
25%
Mouse Model
25%
Ligand Binding
25%
Highly Effective
25%
Receptor Agonist
25%
Transgenic Mouse Model
25%
Clonazepam
25%
Genetic Counseling
25%
Genotype-phenotype Correlation
25%
Pontomedullary
25%
Glycine
25%
Reticle
25%
Drug Choice
25%
Appropriate Treatment
25%
γ-aminobutyric Acid
25%
Apnea
25%
Independent Families
25%
Hypertonia
25%
Autosomal Dominant Disorder
25%
Aspiration Pneumonia
25%
Affected Family Members
25%
Uncommon mutation
25%
Excitability
25%
Startle Reflex
25%
Serious Injury
25%
Spontaneous mutation
25%
Sudden Infant Death
25%
Loss of Ambulation
25%
Frequent Falls
25%
γ-aminobutyric Acid Receptor
25%
Spinal Reciprocal Inhibition
25%
Medicine and Dentistry
Hyperekplexia
100%
Diseases
100%
Glycine Receptor
60%
Chloride Channel
60%
Pathophysiology
20%
Transgenic Mouse
20%
Autosomal Dominant Inheritance
20%
Sudden Infant Death Syndrome
20%
Genetic Counseling
20%
Muscle Hypertonia
20%
GABA Receptor Agonist
20%
Gamma-Aminobutyric Acid
20%
Lipid Pneumonia
20%
Apnea
20%
Excitability
20%
Clonazepam
20%
Spontaneous Mutation
20%
Startle Response
20%
Genotype Phenotype Correlation
20%
Ligand Binding
20%